In an assessment of Haemate P (Heat Treated Factor 8), Dr Fowler concluded that it was probable that Hepatitis B would be less likely with the heat-treated product than with comparable untreated products.
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Regulation of Commercial Factor Concentrates